000 | 01981 a2200517 4500 | ||
---|---|---|---|
005 | 20250517094650.0 | ||
264 | 0 | _c20170731 | |
008 | 201707s 0 0 eng d | ||
022 | _a1527-7755 | ||
024 | 7 |
_a10.1200/JCO.2016.66.7899 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFeldman, Darren R | |
245 | 0 | 0 |
_aPaclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors. _h[electronic resource] |
260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _c07 2016 |
||
300 |
_a2478-83 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIfosfamide _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasms, Germ Cell and Embryonal _xdrug therapy |
650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
650 | 0 | 4 | _aProspective Studies |
700 | 1 | _aHu, James | |
700 | 1 | _aDorff, Tanya B | |
700 | 1 | _aLim, Kristina | |
700 | 1 | _aPatil, Sujata | |
700 | 1 | _aWoo, Kaitlin M | |
700 | 1 | _aCarousso, Maryann | |
700 | 1 | _aHughes, Amanda | |
700 | 1 | _aSheinfeld, Joel | |
700 | 1 | _aBains, Manjit | |
700 | 1 | _aDaneshmand, Siamak | |
700 | 1 | _aKetchens, Charlene | |
700 | 1 | _aBajorin, Dean F | |
700 | 1 | _aBosl, George J | |
700 | 1 | _aQuinn, David I | |
700 | 1 | _aMotzer, Robert J | |
773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 34 _gno. 21 _gp. 2478-83 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2016.66.7899 _zAvailable from publisher's website |
999 |
_c26025890 _d26025890 |